BONE MARROW TRANSPLANTATION

简称 BONE MARROW TRANSPL ·ENGLAND ·出版周期 Semimonthly ·年均收录 164 篇

5.2

最新影响因子

13.00%

自引率

较易

投稿难度

一般,3-8周

审稿周期

期刊简介

BONE MARROW TRANSPLANTATION是一本国际性学术期刊，ISSN号为0268-3369，由Springer Nature出版，出版地为英国，出版周期为月刊。该期刊的影响因子较高，具体数值需查阅最新JCR报告，属于SCI收录期刊，中科院分区通常位于医学领域的二区或三区，为非开放获取（OA）期刊。其发文特点集中于造血干细胞移植及相关领域的研究，包括临床实践、免疫学、移植并发症及新兴治疗技术等。杂志以高质量原创研究、综述和病例报告为主，学术声誉良好，但投稿竞争激烈，审稿周期可能较长，且拒稿率较高，适合领域内的高水平研究者投稿。

影响因子趋势

近期发表

Real-world utilization of thrombopoietin receptor agonists in the italian hematopoietic stem cell transplantation setting: a comprehensive national survey by the Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) 2026-09-18

GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis 2026-09-17

Azacitidine maintenance after allogeneic hematopoietic stem cell transplantation in high-risk AML: a single-center retrospective study 2026-09-14

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS 2026-09-12

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party 2026-09-10

Early deterioration and subsequent recovery of nursing complexity after CAR-T therapy: a prospective score-based analysis 2026-09-05

Early infection post targeted chimeric antigen receptor T-cell therapy in patients with hematologic malignancies: a real-world, single-center, large-scale study 2026-09-04

Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation 2026-09-04

Growth retardation in long-term high-risk neuroblastoma survivors treated with high-dose chemotherapy: the impact of large vertebral irradiation and gonadal damage 2026-09-03

Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT 2026-09-02